NCT07458854

Brief Summary

This interventional study assigns participants undergoing autologous hematopoietic stem cell transplantation to a supervised exercise program or usual care. The exercise program includes strength, endurance, and flexibility sessions for 8 weeks, 5 days per week. The control group receives usual care without a structured exercise program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2014

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2014

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2018

Completed
7.5 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

6 days

First QC Date

February 27, 2026

Last Update Submit

March 4, 2026

Conditions

Keywords

Autologous bone marrow transplantationexercisewhite blood cellneutrophillymphocite

Outcome Measures

Primary Outcomes (1)

  • Change in Handgrip Strength During the Transplantation Process

    Change in handgrip strength measured using a hand dynamometer at four time points: 4 weeks before transplantation, 2 days before transplantation, during the engraftment period, and 2 weeks after engraftment in patients undergoing autologous bone marrow transplantation.

    Baseline (4 weeks before transplantation),pre-transplant (2 days before), during engraftment, and 2 weeks post-engraftment 8(approximately 10-12 weeks total follow-up)

Secondary Outcomes (7)

  • Change in Back Strength

    Baseline (4 weeks before transplantation), pre-transplant (2 days before), during engraftment, and 2 weeks post-engraftment (approximately 10-12 weeks total follow-up).

  • Change in Leg Strength

    Baseline (4 weeks before transplantation), pre-transplant (2 days before), during engraftment, and 2 weeks post-engraftment (approximately 10-12 weeks total follow-up).

  • Change in Waist Flexibility

    Baseline (4 weeks before transplantation), pre-transplant (2 days before), during engraftment, and 2 weeks post-engraftment (approximately 10-12 weeks total follow-up).

  • Change in White Blood Cell Count

    Baseline (4 weeks before transplantation), pre-transplant (2 days before), during engraftment, and 2 weeks post-engraftment (approximately 10-12 weeks total follow-up).

  • Change in Neutrophil Count

    Baseline (4 weeks before transplantation), pre-transplant (2 days before), during engraftment, and 2 weeks post-engraftment (approximately 10-12 weeks total follow-up).

  • +2 more secondary outcomes

Study Arms (2)

Exercise Intervention In Autologous Stem Cell Transplant Patients:A Randomized Controlled Trial

EXPERIMENTAL

The Exercise Group consisted of patients scheduled to undergo autologous bone marrow transplantation who were randomly assigned to the intervention arm of the study. Initial number of participants: 12 Included in final analysis: 8 Intervention: * 8-week structured exercise program * Performed 5 days per week * Included endurance, strength, and flexibility exercises Exercise intensity was determined using the 1-repetition maximum (1RM) principle for resistance training and the Karvonen method (40-60%) for aerobic training. Exercise intensity was monitored using the 24-point Borg Scale. In addition to standard medical treatment, this group received a structured therapeutic exercise program.

Behavioral: Exercise Program

Exercise Intervention-Free Randomized Controlled Study in Autogenous Stem Cell Transplant Patients

NO INTERVENTION

The Control Group consisted of patients randomly assigned to the control arm of the study. Initial number of participants: 12 Included in final analysis: 7 Intervention: * Standard medical treatment only * No structured exercise program was implemented This group served as the comparison group.

Interventions

8-week structured strength, endurance and flexibility exercise program performed 5 days per week. Resistance intensity was determined using 1RM, aerobic intensity using Karvonen method (40-60%), monitored with Borg Scale

Exercise Intervention In Autologous Stem Cell Transplant Patients:A Randomized Controlled Trial

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years, \<65 years
  • Able to exercise at time of enrolment.
  • no methastasis

You may not qualify if:

  • Contraindications to 3 T MRI (e.g., pacemaker or implanted metallic device).
  • co-morbid cardiac disease
  • painful joint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University Faculty of Sport Science

Kayseri, Kayseri, 38039, Turkey (Türkiye)

Location

Related Publications (4)

  • Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L. A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant. 2009 May;43(9):725-37. doi: 10.1038/bmt.2009.27. Epub 2009 Feb 23.

    PMID: 19234513BACKGROUND
  • Wiskemann J, Huber G. Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 Feb;41(4):321-9. doi: 10.1038/sj.bmt.1705917. Epub 2007 Nov 19.

    PMID: 18026154BACKGROUND
  • Baumann FT, Kraut L, Schule K, Bloch W, Fauser AA. A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant. 2010 Feb;45(2):355-62. doi: 10.1038/bmt.2009.163. Epub 2009 Jul 13.

    PMID: 19597418BACKGROUND
  • Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood. 1997 Nov 1;90(9):3390-4.

    PMID: 9345021BACKGROUND

MeSH Terms

Conditions

Motor Activity

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Mustafa Karakuş, PhD

    TC Erciyes University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors and data analysts were blinded to group allocation. Due to the nature of the exercise intervention, participants and exercise supervisors were not blinded.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: analyses were completed with 8 patients in the exercise group and 7 patients in the control group. The exercise group participated in an 8-week exercise program consisting of endurance, strength, and flexibility exercises performed five days per week. The 1-repetition maximum (1RM) principle was used to determine resistance training intensity, while the Karvonen method (40-60%) was used to prescribe aerobic exercise intensity. Exercise intensity was monitored using the 24-point Borg Scale. The control group did not participate in any structured exercise program. Assessments were conducted at four time points: 1. Four weeks before transplantation 2. Two days before transplantation 3. During the engraftment period 4. Two weeks after engraftment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 9, 2026

Study Start

October 14, 2014

Primary Completion

October 20, 2014

Study Completion

September 10, 2018

Last Updated

March 9, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to institutional data protection policies and ethical restrictions

Locations